Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
- Resource Type
- article
- Source
- Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
- Subject
Science - Language
- English
- ISSN
- 2041-1723